Stock picking is tough. Stock investing is riskier, compared to mutual funds. But picking and holding the right stock over the long term can make you wealthy. Here’s our top stock pick for the August 31-September 4 trading week. Check out our previous weekly stock picks.
Tandem Diabetes Care, Inc. (TNDM)
Let’s take you to the Healthcare sector and Medical Devices industry with Tandem Diabetes Care (TNDM). Tandem Diabetes Care, Inc. is a medical device company that designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. You probably know a person or two with diabetes. Without boring you with statistics, let’s just say Tandem Diabetes (TNDM) is a stock you may want to add to your portfolio for massive wealth! The company allows insulin-dependent diabetic patients to easily manage their diabetes with its various delivery devices and pumps. Learn more about Tandem Diabetes Care.
We previously recommended this stock on 04/14/2020 when it was trading at $66.98. As of 08/29/2020, the stock is now trading at $112.96. TNDM hit a 52-week high of $114.00 on 08/28/2020. It reached a 52-week low of $43.69 on 03/18/2020 at the height of the coronavirus pandemic. TNDM has rewarded investors richly.
[RELATED: Dear Mr. Coronavirus. Thank you for the lemons. We’re making lemonade.]
Courtesy of Tandem Diabetes Care.
| YTD (%) | 1M (%) | 6M (%) | 1YR (%) | 5YR (%) | |
| TNDM | +86.78 | +12.73 | +49.13 | +57.88 | +0.85% |
| S&P 500 | +8.58 | +9.00 | +18.75 | +21.457 | +76.38 |
The bottom line
The secret to building sustainable wealth is two-fold: invest in companies with solid business fundamentals; hold them for the long term. Tandem Diabetes Care is one of such companies. According to the American Diabetes Association, 10.5% of the U.S. population or 34.2 million people had diabetes in 2018. It is estimated that 1.5 million Americans are diagnosed with diabetes annually. As long as diabetes continues to be prevalent, we believe TNDM is poised for excellent growth. For more information about the stock, visit the investor relations page.
Do you have better stock ideas? Please share with us in the comment section.
Disclosure: We have no positions in any of the stocks mentioned above. This article expresses our opinions. We do not receive compensation from the companies highlighted, nor do we have any business relationships with them. All data is current as of the date of article publication. This article contains affiliated links to investment products. We may receive a commission through those links when you join the partner. Information presented here should not be construed as financial advice. You are always encouraged to conduct your own research. Our full disclaimer.
